Skip to Content
Crinetics Logo
  • Contact Us
    • Partnering
    • Funding & Support
    • Charitable Contributions & Sponsorships
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Ethics & Compliance
  • Patients
    • Advocacy Partners
    • Expanded Access Policy
    • Newsletter Signup
  • Our Science
    • Our Approach
    • Discovery Engine
    • Pipeline
      • Paltusotine, Oral SST2 Agonist
      • Atumelnant, Oral ACTH Antagonist
      • CRN09682 (NonPeptide Drug Conjugate)
    • Therapeutic Areas
  • Medicines
  • Publications
  • News & Events
    • Press Releases
    • Events
    • ENDO 2025
  • Featured Perspectives
  • Investors
    • Events and Presentations
    • Analyst Coverage
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Careers
    • Join Us
    • Values
    • Culture
    • Benefits
  • Contact Us
    • Partnering
    • Funding & Support
    • Charitable Contributions & Sponsorships

Be the first to know about the advances we're making in endocrine-rooted care.

Patient Newsletter Subscribe Form

Collect Patient Newsletter Signups on /patients/ page.

This field is for validation purposes and should be left unchanged.
Name
This field is hidden when viewing the form
Consent(Required)
Crinetics Logo
Location Icon 6055 Lusk Blvd, San Diego, CA
Phone Number (858) 450-6464

© 2026 Crinetics Pharmaceuticals, Inc. All rights reserved.

  • Our Company
  • Patients
  • Our Science
  • Medicines
  • Publications
  • News & Events
  • Featured Perspectives
  • Investors
  • Careers
  • Join Us
  • Contact Us
  • Terms of Use
  • Privacy Policy
Facebook Logo X Logo YouTube Logo LinkedIn Logo
You are about to leave our site

You are now leaving Crinetics.com

CONTINUE
You are now leaving Crinetics.com

Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.

CONTINUE Arrow